EE508 Healthcare Resource Utilization (HCRU) Analysis in Newly Diagnosed Mantle Cell Lymphoma: Autologous Stem Cell Transplantation (ASCT) and (HCRU) Alleviation With Adoption of the TRIANGLE Ibrutinib Regimen Without (ASCT)
Abstract
Authors
Jonas Wisskirchen Nora Rogmann Michael Greiling Frederic Ries Anke Ohler Georg Hess Julia Osygus